The effects of homocysteine and folic acid on angiogenesis and VEGF expression during chicken vascular development

Microvascular Research

Volumn 83, Issue 2, 2012, Pages 98-104

  Oosterbaan, Annelien M ^a   Steegers, Eric A P ^a   Ursem, Nicolette T C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; BLOOD VESSEL DIAMETER; CHICK EMBRYO; COMPUTER PROGRAM; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; IMAGE ANALYSIS; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; BLOOD VESSELS; CHICK EMBRYO; DOWN-REGULATION; EXTRAEMBRYONIC MEMBRANES; FOLIC ACID; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HOMOCYSTEINE; IMAGE PROCESSING, COMPUTER-ASSISTED; NEOVASCULARIZATION, PHYSIOLOGIC; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84856801910     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2011.11.001     Document Type: Article

References (33)

1. Au-Yeung K.K., et al. Hyperhomocysteinemia activates nuclear factor-kappaB in endothelial cells via oxidative stress. Circ. Res. 2004, 94:28-36.
2. Boot M.J., et al. Homocysteine induces endothelial cell detachment and vessel wall thickening during chick embryonic development. Circ. Res. 2004, 94:542-549.
3. Breier G., et al. Angiogenesis in embryos and ischemic diseases. Thromb. Haemost. 1997, 78:678-683.
4. Chambers J.C., Kooner J.S. Homocysteine-an innocent bystander in vascular disease?. Eur. Heart J. 2001, 22:717-719.
5. Ferrara N., Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr. Rev. 1997, 18:4-25.
6. Ferrara N., et al. The biology of VEGF and its receptors. Nat. Med. 2003, 9:669-676.
7. Goh Y.I., et al. Prenatal multivitamin supplementation and rates of congenital anomalies: a meta-analysis. J. Obstet. Gynaecol. Can. 2006, 28:680-689.
8. Groenendijk B.C., et al. Changes in shear stress-related gene expression after experimentally altered venous return in the chicken embryo. Circ. Res. 2005, 96:1291-1298.
9. Hansen D.K., et al. Lack of embryotoxicity of homocysteine thiolactone in mouse embryos in vitro. Reprod. Toxicol. 2001, 15:239-244.
10. Harker L.A., et al. Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J. Clin. Invest. 1976, 58:731-741.
11. Hossain G.S., et al. TDAG51 is induced by homocysteine, promotes detachment-mediated programmed cell death, and contributes to the cevelopment of atherosclerosis in hyperhomocysteinemia. J. Biol. Chem. 2003, 278:30317-30327.
12. Latacha K.S., Rosenquist T.H. Homocysteine inhibits extra-embryonic vascular development in the avian embryo. Dev. Dyn. 2005, 234:323-331.
13. Lee S.J., et al. Nitric oxide inhibition of homocysteine-induced human endothelial cell apoptosis by down-regulation of p53-dependent Noxa expression through the formation of S-nitrosohomocysteine. J. Biol. Chem. 2005, 280:5781-5788.
14. Loscalzo J. The oxidant stress of hyperhomocyst(e)inemia. J. Clin. Invest. 1996, 98:5-7.
15. McCully K.S. Homocysteine, vitamins, and vascular disease prevention. Am. J. Clin. Nutr. 2007, 86:1563S-1568S.
16. Nagai Y., et al. Homocysteine inhibits angiogenesis in vitro and in vivo. Biochem. Biophys. Res. Commun. 2001, 281:726-731.
17. Neufeld G., et al. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999, 13:9-22.
18. Resnick N., et al. Hemodynamic forces as a stimulus for arteriogenesis. Endothelium 2003, 10:197-206.
19. Rolschau J., et al. Folic acid supplement and intrauterine growth. Acta Obstet. Gynecol. Scand. 1979, 58:343-346.
20. Rolschau, J., et al., 1999. The influence of folic acid supplement on the outcome of pregnancies in the county of Funen in Denmark. Part I. Eur J Obstet Gynecol Reprod Biol. 87, 105-10; discussion 103-4.
21. Rosenquist T.H., et al. Homocysteine induces congenital defects of the heart and neural tube: effect of folic acid. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:15227-15232.
22. Schiessl B., et al. Localization of angiogenic growth factors and their receptors in the human placental bed throughout normal human pregnancy. Placenta 2009, 30:79-87.
23. Smith A.D., et al. Is folic acid good for everyone?. Am. J. Clin. Nutr. 2008, 87:517-533.
24. Timmermans S., et al. Periconception folic acid supplementation, fetal growth and the risks of low birth weight and preterm birth: the Generation R Study. Br. J. Nutr. 2009, 102:777-785.
25. Upchurch G.R., et al. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J. Biol. Chem. 1997, 272:17012-17017.
26. van Mil N.H., et al. Teratogenicity and underlying mechanisms of homocysteine in animal models: a review. Reprod. Toxicol. 2010, 30 (4):520-531.
27. Verkleij-Hagoort A., et al. Hyperhomocysteinemia and MTHFR polymorphisms in association with orofacial clefts and congenital heart defects: a meta-analysis. Am. J. Med. Genet. A. 2007, 143A:952-960.
28. Vickerman M.B., et al. VESGEN 2D: automated, user-interactive software for quantification and mapping of angiogenic and lymphangiogenic trees and networks. Anat. Rec. (Hoboken) 2009, 292:320-332.
29. Wall R.T., et al. Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb. Res. 1980, 18:113-121.
30. Welch G.N., et al. Homocysteine-induced nitric oxide production in vascular smooth-muscle cells by NF-kappa B-dependent transcriptional activation of Nos2. Proc. Assoc. Am. Physicians 1998, 110:22-31.
31. Yue X., Tomanek R.J. Effects of VEGF(165) and VEGF(121) on vasculogenesis and angiogenesis in cultured embryonic quail hearts. Am. J. Physiol. Heart Circ. Physiol. 2001, 280:H2240-H2247.
32. Zabihi S., et al. Folic acid supplementation affects ROS scavenging enzymes, enhances Vegf-A, and diminishes apoptotic state in yolk sacs of embryos of diabetic rats. Reprod. Toxicol. 2007, 23:486-498.
33. Zhang C., et al. Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response. J. Biol. Chem. 2001, 276:35867-35874.